Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-04-01

Clinical Trial Update: Sevoflurane Sedation in Patients With Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sevoflurane for sedation in septic shock; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: University of Zurich | Conditions: Shock, Septic | Phase 2 | Status: NOT_YET_RECRUITING